Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial

AIMS: Reducing alcohol consumption is one treatment approach for alcohol‐dependent patients. This study compared nalmefene 20 mg and 10 mg with placebo, combined with psychosocial support, in alcohol‐dependent Japanese patients with a high or very high drinking risk level (DRL). METHODS: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Hisatsugu, Takahashi, Masayoshi, Murai, Yoshiyuki, Tsuneyoshi, Kana, Hayashi, Takako, Meulien, Didier, Sørensen, Per, Higuchi, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899457/
https://www.ncbi.nlm.nih.gov/pubmed/31298784
http://dx.doi.org/10.1111/pcn.12914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899457/
https://www.ncbi.nlm.nih.gov/pubmed/31298784
http://dx.doi.org/10.1111/pcn.12914

Ejemplares similares